W. Watson

W. Watson has a diverse work experience that spans multiple industries. W. is currently working as a Director for Vaxart, Inc. and Tekla Capital Management, starting in 2022 for both positions. In 2014, they joined Global Health as a Director/Investor and Chair of the Audit Committee. Prior to that, in 2008, they served as a Board Member and Chair of the Audit Committee at Moffitt Cancer Center. From 2018 to 2022, they worked as a Director at Sykes Enterprises, Incorporated. W. also held roles as a Director at BioDelivery Sciences International from 2017 to 2022 and as the Chairman of the Board and the Audit Committee at INHIBITOR Therapeutics, Inc. from 2014 to 2022. Additionally, they served as the Past Chairman of the Board at The Florida Aquarium from 2008 to 2022.

W. Watson attended Marquette University from 1968 to 1972, where they earned a Bachelor of Science in Business Administration (BSBA) with a specialization in Accounting. No information is provided about any additional certifications W. Watson may have obtained.